Male Infertility in India: Why Half of Infertility Is About Sperm

When a couple struggles to conceive, the first investigation is almost always focused on the woman — hormonal panels, ultrasounds, tubal assessments. The man's contribution to the fertility equation is frequently assessed last, if at all, even though male factor infertility is involved in approximately 40 to 50% of all cases presenting to fertility clinics in India. In approximately 20 to 30% of cases, male factor is the sole cause of infertility.

This asymmetry in investigation priority is not supported by evidence. A semen analysis is one of the simplest, least invasive, and most informative first-line fertility investigations available — and it should be performed in parallel with female investigations, not as an afterthought after months of female-focused workup.

This guide covers everything you need to know about male infertility: what it is, how it is assessed, what causes it, and what the realistic treatment options are.

Male Infertility: How Common Is It Really?

Male infertility is far more common than social norms around masculinity allow most men to acknowledge. In India, where cultural identity is often tied to male sexual potency, a diagnosis of poor sperm quality can feel devastating — and this emotional weight frequently delays men from being assessed at all.

The data are clear: male factor is involved in roughly half of all infertile couples. Of those with male factor:

• Approximately 40% have low sperm count (oligospermia)
• Approximately 40% have poor sperm motility (asthenospermia)
• Approximately 15% have severely abnormal sperm morphology (teratospermia)
• Approximately 10 to 15% have complete absence of sperm in the ejaculate (azoospermia)
• Many men have a combination of these — oligoasthenoteratospermia (OAT syndrome)

These numbers underscore why the male partner is not a secondary investigation — he is half the fertility equation from the first appointment.

How Sperm Is Produced: The Basics

Sperm production (spermatogenesis) occurs in the seminiferous tubules of the testes. The process begins with spermatogonial stem cells and proceeds through multiple developmental stages over approximately 72 to 74 days — roughly three months from stem cell to mature sperm. Mature sperm are stored and further developed in the epididymis before being transported through the vas deferens during ejaculation.

Three conditions are essential for normal sperm production:

• Adequate hormonal signalling from the hypothalamic-pituitary-gonadal axis — FSH and LH from the pituitary, testosterone from the testes
• Optimal testicular temperature — approximately 2 to 4°C below core body temperature, which is why the testes are located outside the body
• Intact delivery anatomy — the vas deferens, seminal vesicles, prostate, and ejaculatory ducts must all be structurally normal

Disruption to any of these — hormonal, thermal, structural, or genetic — can impair sperm production, transport, or quality.

Categories of Male Infertility

Pre-Testicular (Hormonal) Causes

Pre-testicular causes involve abnormal hormonal signalling to the testes, resulting in reduced stimulation of sperm production. The most important example is hypogonadotrophic hypogonadism — low levels of FSH and LH from the pituitary, which fails to adequately drive testicular function. This can be congenital (Kallmann syndrome) or acquired (from a pituitary tumour, elevated prolactin, or the use of exogenous testosterone or anabolic steroids). Importantly, hormonal causes of male infertility are among the most treatable — gonadotrophin injections can stimulate sperm production in many cases of hypogonadotrophic hypogonadism.

Testicular Causes

Testicular causes reflect intrinsic problems with the sperm-producing machinery of the testes:

• Genetic: Klinefelter syndrome (47XXY) is the most common genetic cause of male infertility, present in approximately 1 in 500 men. Y chromosome microdeletions — deletions in the AZFa, AZFb, or AZFc regions of the Y chromosome — impair sperm production and are found in approximately 15% of men with non-obstructive azoospermia.
• Cryptorchidism: Undescended testes during childhood, even when surgically corrected, cause lasting impairment to spermatogenesis proportional to the duration of maldescent. Bilateral cryptorchidism significantly increases infertility risk.
• Varicocele: Dilated veins in the scrotum elevate testicular temperature and create oxidative stress, impairing spermatogenesis. The most common correctable cause of male infertility.
• Previous infection: Orchitis (testicular infection) — particularly from mumps in post-pubertal men — can permanently damage the sperm-producing tubules.
• Previous chemotherapy or radiation: Gonadotoxic cancer treatment is a major cause of testicular failure.

Post-Testicular (Obstructive) Causes

Sperm production may be normal, but a physical blockage prevents sperm from reaching the ejaculate:

• Congenital bilateral absence of the vas deferens (CBAVD): The tubes carrying sperm from the testes are absent from birth — strongly associated with CFTR gene mutations (the gene responsible for cystic fibrosis).
• Previous vasectomy: Voluntary sterilisation is the most common cause of obstructive azoospermia globally.
• Epididymal obstruction: From previous infection (chlamydia, gonorrhoea) or trauma.
• Ejaculatory duct obstruction: Can cause very low semen volume with absence of sperm or fructose.

The Semen Analysis: First-Line Male Assessment

The semen analysis remains the cornerstone of male fertility assessment. WHO 2021 reference values (lower reference limits) for semen parameters are:

• Volume: ≥ 1.4 ml
• Total sperm count: ≥ 39 million per ejaculate
• Concentration: ≥ 16 million per ml
• Total motility (progressive + non-progressive): ≥ 42%
• Progressive motility: ≥ 30%
• Morphology (strict Kruger criteria): ≥ 4% normal forms
• Vitality (live sperm): ≥ 54%

A single abnormal result requires a repeat test — semen quality varies significantly between samples, influenced by abstinence period (ideally 3 to 5 days), illness, stress, and laboratory conditions. Two abnormal results on properly collected samples are required before drawing clinical conclusions.

Beyond the Semen Analysis: When Further Testing Is Needed

The standard semen analysis does not capture every dimension of sperm health. Additional investigations are indicated in specific clinical contexts:

• Sperm DNA fragmentation (DFI): Measures the proportion of sperm with damaged DNA strands. A normal semen analysis does not exclude high DNA fragmentation, which is associated with failed fertilisation, poor embryo quality, and recurrent miscarriage. Essential investigation in couples with repeated IVF failure or recurrent pregnancy loss.
• Hormonal panel: FSH, LH, testosterone, prolactin — to identify hormonal causes of male infertility and assess testicular function.
• Karyotype and Y chromosome microdeletion analysis: For men with severe oligospermia (below 5 million per ml) or azoospermia.
• CFTR mutation testing: For men with CBAVD (no palpable vas deferens) or very low semen volume.
• Scrotal and transrectal ultrasound: To detect varicocele, testicular abnormalities, and ejaculatory duct obstruction.
• Testicular biopsy: In selected cases of azoospermia, to determine whether sperm production is occurring in the testes even when absent from the ejaculate.

Treatment Options for Male Infertility

Lifestyle Optimisation

Many common lifestyle factors significantly impair sperm quality — and most are reversible within 3 to 6 months (one spermatogenesis cycle). Stopping smoking, reducing alcohol, losing weight if obese, avoiding heat exposure, stopping anabolic steroids — these measures should be instituted at least 3 months before any fertility treatment cycle. They do not replace medical treatment where it is indicated, but they powerfully support it.

Medical Treatment

For hormonal causes — hypogonadotrophic hypogonadism, hyperprolactinaemia — targeted medical treatment can restore sperm production dramatically. Gonadotrophin injections (FSH and hCG) in hypogonadotrophic hypogonadism can produce sperm in men who had none. Cabergoline in hyperprolactinaemia normalises testosterone and can restore spermatogenesis. These are the most rewarding male infertility outcomes in clinical practice.

Surgical Treatment

Varicocelectomy (surgical repair of a varicocele) can significantly improve semen parameters in appropriately selected men. Vasovasostomy (vasectomy reversal) restores natural fertility in men who have undergone vasectomy — outcomes depend on the time elapsed since vasectomy and the technique used. Transurethral resection of ejaculatory ducts can relieve obstruction in selected cases.

Sperm Retrieval for IVF/ICSI

For men with azoospermia, sperm can often be surgically retrieved directly from the epididymis (PESA) or testis (TESA, micro-TESE) and used with ICSI to achieve fertilisation. Obstructive azoospermia has near-universal sperm retrieval rates. Non-obstructive azoospermia achieves retrieval in approximately 40 to 60% with micro-TESE.

Antioxidant Supplementation

Oxidative stress is the single most common mechanism of sperm DNA damage. Antioxidant supplementation — combining vitamin C, vitamin E, CoQ10, zinc, folate, selenium, and lycopene — reduces oxidative damage and can significantly improve DNA fragmentation indices over 3 to 6 months. It is a safe, accessible, first-line adjunct for most men with sperm quality issues.

The Genetic Dimension: What Male Factor Means for Children

Some genetic causes of male infertility can be transmitted to children conceived through ICSI. Y chromosome microdeletions in the AZFc region are transmitted from father to son — male children conceived using sperm from an AZFc-deleted father will inherit the deletion and the infertility. Klinefelter syndrome (47XXY) is generally not inherited in the classical sense (it arises de novo in most cases), but there is a slightly elevated risk of chromosomal abnormalities in the offspring.

Genetic counselling before sperm retrieval and ICSI is essential for men with genetic causes of azoospermia or severe oligospermia. At Solo Clinic, this is part of the standard pre-treatment consultation for relevant cases.

Frequently Asked Questions

Q1. Does male infertility affect sexual performance?

No. Sperm quality has no relationship to sexual desire, erection, or ejaculation. The sperm are too small to be detectable, and semen volume and appearance are determined primarily by secretions from the seminal vesicles and prostate — not by the sperm themselves. A man with zero sperm count will have a completely normal appearing ejaculate in normal volume. This is one reason why azoospermia is often so surprising — there is no symptomatic warning.

Q2. If my semen analysis is normal, am I definitely fertile?

Not necessarily. A normal standard semen analysis excludes most significant sperm quantity and motility problems, but it does not assess DNA fragmentation, which can be severely elevated despite normal parameters. It also does not assess the functional capacity of sperm to fertilise an egg or the genetic quality of sperm. A normal semen analysis is reassuring — but if IVF produces poor embryo quality or fails to produce a pregnancy, sperm DNA fragmentation should be the next investigation.

Q3. How long does it take for sperm quality to improve after lifestyle changes?

Spermatogenesis takes approximately 72 to 74 days — roughly 3 months. Any lifestyle change made today will take approximately 3 months to be reflected in a semen analysis. This is why lifestyle optimisation should be started at least 3 months before a planned fertility treatment cycle, and why a repeat semen analysis after 3 months of lifestyle change is informative.

Q4. Should the male partner be assessed at the same time as the female partner?

Yes — absolutely. Investigating both partners simultaneously is more efficient, more equitable, and more clinically sound. Waiting for female investigations to be complete before assessing the male partner wastes months of potentially valuable time. A semen analysis should be ordered at the first fertility consultation, in parallel with the female hormonal panel and ultrasound.